Awareness, knowledge, attitude, and practice of adverse drug reaction reporting among health workers in primary health centres participating in seasonal malaria chemoprevention campaign in Nigeria in 2022: a cross-sectional survey
Abstract Background Evaluating health workers’ knowledge and practice of adverse drug reaction (ADR) reporting is an important step in identifying gaps in quality ADR reporting during public health interventions like the seasonal malaria chemoprevention (SMC) campaign. Pharmacovigilance (PV) monitor...
| Published in: | BMC Health Services Research |
|---|---|
| Main Authors: | Kunle Rotimi, Babatunde Fagbemi, Grace Omole, Aminu Ahmed Biambo, Taiwo Ibinaiye, Azuka Iwegbu, Olabisi Ogunmola, Chibuzo Oguoma, Olusola Oresanya |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-08-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12913-024-11343-y |
Similar Items
Private sector availability and affordability of under 5 malaria health commodities in selected states in Nigeria and the Federal Capital Territory
by: Kunle Rotimi, et al.
Published: (2024-12-01)
by: Kunle Rotimi, et al.
Published: (2024-12-01)
Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022
by: Kunle Rotimi, et al.
Published: (2023-05-01)
by: Kunle Rotimi, et al.
Published: (2023-05-01)
Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo
by: Taiwo Ibinaiye, et al.
Published: (2023-05-01)
by: Taiwo Ibinaiye, et al.
Published: (2023-05-01)
Urban–rural differences in seasonal malaria chemoprevention coverage and characteristics of target populations in nine states of Nigeria: a comparative cross-sectional study
by: Taiwo Ibinaiye, et al.
Published: (2024-01-01)
by: Taiwo Ibinaiye, et al.
Published: (2024-01-01)
Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria
by: Taiwo Ibinaiye, et al.
Published: (2024-03-01)
by: Taiwo Ibinaiye, et al.
Published: (2024-03-01)
Correction: Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria
by: Taiwo Ibinaiye, et al.
Published: (2024-04-01)
by: Taiwo Ibinaiye, et al.
Published: (2024-04-01)
Adherence to referral advice and its associated factors among community drug distributors and caregiver during SMC implementation in nine states
by: Taiwo Ibinaiye, et al.
Published: (2024-10-01)
by: Taiwo Ibinaiye, et al.
Published: (2024-10-01)
Predictors of accessing seasonal malaria chemoprevention medicines through non-door-to-door distribution in Nigeria
by: Sikai Huang, et al.
Published: (2024-05-01)
by: Sikai Huang, et al.
Published: (2024-05-01)
From efficacy to effectiveness: a comprehensive framework for monitoring, evaluating and optimizing seasonal malaria chemoprevention programmes
by: Monica Anna de Cola, et al.
Published: (2024-02-01)
by: Monica Anna de Cola, et al.
Published: (2024-02-01)
Delivering insecticide-treated nets (ITNs) through a digitized single-phase door-to-door strategy: lessons from Ondo state, Nigeria
by: Laitan Adeniyi, et al.
Published: (2024-10-01)
by: Laitan Adeniyi, et al.
Published: (2024-10-01)
Optimizing the role of ‘lead mothers’ in seasonal malaria chemoprevention (SMC) campaigns: formative research in Kano State, northern Nigeria
by: Ekechi Okereke, et al.
Published: (2023-01-01)
by: Ekechi Okereke, et al.
Published: (2023-01-01)
Delivering an insecticide-treated net campaign in a complex operating environment: lessons from Anambra state, Nigeria
by: Laitan Adeniyi, et al.
Published: (2025-10-01)
by: Laitan Adeniyi, et al.
Published: (2025-10-01)
A cost analysis comparing seasonal malaria chemoprevention with and without Vitamin A supplementation among under-5 children in Nigeria.
by: Olusola Bukola Oresanya, et al.
Published: (2025-01-01)
by: Olusola Bukola Oresanya, et al.
Published: (2025-01-01)
Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers
by: A. E. Krasheninnikov, et al.
Published: (2021-10-01)
by: A. E. Krasheninnikov, et al.
Published: (2021-10-01)
Monitoring of adverse drug reactions is an important task of pharmacovigilance. Analysis of the regional department of State Expert Center of the Ministry of Health of Ukraine in Zaporizhzhia region
by: O. V. Kraydashenko, et al.
Published: (2017-04-01)
by: O. V. Kraydashenko, et al.
Published: (2017-04-01)
Probing the in-depth analysis of Serious Adverse Drug Reactions in a tertiary care hospital of Central India
by: Preeti Singh, et al.
Published: (2025-03-01)
by: Preeti Singh, et al.
Published: (2025-03-01)
Case reports as early safety signals: learning from the COVID-19 vaccination campaign
by: Michel Goldman, et al.
Published: (2024-01-01)
by: Michel Goldman, et al.
Published: (2024-01-01)
Preparation for the Inspection of the Pharmacovigilance System
by: B. K. Romanov
Published: (2021-10-01)
by: B. K. Romanov
Published: (2021-10-01)
Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications
by: Herieth Ismael Wilson, et al.
Published: (2020-11-01)
by: Herieth Ismael Wilson, et al.
Published: (2020-11-01)
Pharmacovigilance: A brief glimpse
by: Roy Jobson
Published: (2003-05-01)
by: Roy Jobson
Published: (2003-05-01)
The Role of Pharmacist in the Health Care System: Current Scenario in India
by: Saurabh Nimesh
Published: (2020-05-01)
by: Saurabh Nimesh
Published: (2020-05-01)
Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign—A Case of Measles–Rubella and Polio Vaccines
by: Dan Kajungu, et al.
Published: (2021-11-01)
by: Dan Kajungu, et al.
Published: (2021-11-01)
Knowledge and perception of medication errors among health care workers in Ahmadu Bello University Teaching Hospital Zaria, Kaduna State, North-west Nigeria
by: Mu'awiyyah Babale Sufiyan, et al.
Published: (2023-01-01)
by: Mu'awiyyah Babale Sufiyan, et al.
Published: (2023-01-01)
Pharmacovigilance in veterinary profession
by: Fatih Doğan
by: Fatih Doğan
A pharmacovigilance Study on Critically Ill Patients Admitted In Beni-Suef University Teaching Hospital.
by: Alshimaa Mohamed Abdelmohymen, et al.
Published: (2021-06-01)
by: Alshimaa Mohamed Abdelmohymen, et al.
Published: (2021-06-01)
Analysis of Noncompliances with Legislative Requirements in Pharmacovigilance Materials of Registration Dossiers
by: E. O. Zhuravleva, et al.
Published: (2021-12-01)
by: E. O. Zhuravleva, et al.
Published: (2021-12-01)
Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
by: M. Abdrakhmanov, et al.
Published: (2022-04-01)
by: M. Abdrakhmanov, et al.
Published: (2022-04-01)
Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier
by: I. I. Snegireva, et al.
Published: (2020-12-01)
by: I. I. Snegireva, et al.
Published: (2020-12-01)
Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023
by: Yihan Yang, et al.
Published: (2024-07-01)
by: Yihan Yang, et al.
Published: (2024-07-01)
Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)
A Retrospective Study on Adverse Drug Reactions of Anticancer Drugs in a Tertiary Care Hospital in Northeast India
by: Swagata Datta, et al.
Published: (2021-11-01)
by: Swagata Datta, et al.
Published: (2021-11-01)
Perspective of undergraduate health-care students on adverse drug reaction and pharmacovigilance
by: Ahmed Atia, et al.
Published: (2023-01-01)
by: Ahmed Atia, et al.
Published: (2023-01-01)
Centredness in health care: A systematic overview of reviews
by: Caroline Feldthusen, et al.
Published: (2022-06-01)
by: Caroline Feldthusen, et al.
Published: (2022-06-01)
Training in post-authorization pharmacovigilance
by: Vivek Ahuja, et al.
Published: (2010-01-01)
by: Vivek Ahuja, et al.
Published: (2010-01-01)
Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
by: N. Yu. Velts, et al.
Published: (2023-03-01)
by: N. Yu. Velts, et al.
Published: (2023-03-01)
Awareness of Digital Reporting of Adverse Drug Events among Health Care Professionals
by: Shweta Sharma, et al.
Published: (2023-09-01)
by: Shweta Sharma, et al.
Published: (2023-09-01)
Review of public health commodity distribution models in Nigeria
by: Kunle Rotimi
Published: (2024-05-01)
by: Kunle Rotimi
Published: (2024-05-01)
The comparative evaluation of knowledge, attitude, and practice of different health-care professionals about the pharmacovigilance system of India
by: Asmatanzeem Bepari, et al.
Published: (2019-01-01)
by: Asmatanzeem Bepari, et al.
Published: (2019-01-01)
Ground Penetrating Radar for Monitoring Damage in Reinforced Concrete Bridges: A Reliable Tool for Structural Health Assessment
by: Olumuyiwa Falowo, et al.
Published: (2024-07-01)
by: Olumuyiwa Falowo, et al.
Published: (2024-07-01)
Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis
by: Jaehyeong Cho, et al.
Published: (2025-08-01)
by: Jaehyeong Cho, et al.
Published: (2025-08-01)
Similar Items
-
Private sector availability and affordability of under 5 malaria health commodities in selected states in Nigeria and the Federal Capital Territory
by: Kunle Rotimi, et al.
Published: (2024-12-01) -
Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022
by: Kunle Rotimi, et al.
Published: (2023-05-01) -
Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo
by: Taiwo Ibinaiye, et al.
Published: (2023-05-01) -
Urban–rural differences in seasonal malaria chemoprevention coverage and characteristics of target populations in nine states of Nigeria: a comparative cross-sectional study
by: Taiwo Ibinaiye, et al.
Published: (2024-01-01) -
Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria
by: Taiwo Ibinaiye, et al.
Published: (2024-03-01)
